CAP Pilot Study for Obstructive Sleep Apnea (OSA)
1 other identifier
observational
50
1 country
2
Brief Summary
This is a pilot to review the feasibility of a program that assists patients towards therapy compliance by scheduled intervention through the first month of therapy. The hypothesis of this study is that the trial program will function as intended and average patient adherence will be over 4 hours per night.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2013
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 2, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedFirst Posted
Study publicly available on registry
December 5, 2014
CompletedDecember 8, 2014
December 1, 2014
1.4 years
April 2, 2013
December 4, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Accuracy of delivery of SMS messages to participant
Cross check recieved messages logged in a diary by the participant to those sent by CAP
30 days
Secondary Outcomes (1)
Participant CPAP Adherence
30 nights
Study Arms (1)
Naive cohort
Interventions
Eligibility Criteria
Sleep laboratory, DME supplier
You may qualify if:
- to 75 years of age
- Diagnosed with OSA (AHI \>5 events/hour) and eligible for Continuous Positive Airway Pressure (CPAP) treatment under local requirements
- Must be initiated on program (i.e. received their device) within 12 weeks of CPAP titration study
- Naïve to CPAP therapy, i.e have not been prescribed CPAP in the past
- Access to a cellphone
You may not qualify if:
- Contraindicated for CPAP therapy
- Medically unstable condition/diagnosis that is not yet under control
- Co-existing sleep disorder (however clinically diagnosed insomnia can be included in the study)
- Periodic Leg MOvement Arousal Index greater than 15/hr
- Home titration of longer than 5 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Clayton Sleep Institute
St Louis, Missouri, United States
Sleep Therapy Research Center
San Antonio, Texas, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 2, 2013
First Posted
December 5, 2014
Study Start
April 1, 2013
Primary Completion
September 1, 2014
Study Completion
December 1, 2014
Last Updated
December 8, 2014
Record last verified: 2014-12